市場調査レポート

商品コード

1619239

避妊薬の市場規模、シェア、成長分析、製品別、流通チャネル別、地域別 - 産業別予測、2024～2031年

Contraceptives Market Size, Share, Growth Analysis, By Product (Contraceptive Drugs, Contraceptive Pills), By Distribution Channel (Healthcare Facilities, Pharmacies), By Region - Industry Forecast 2024-2031

出版日: 2024年12月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

避妊薬市場規模は2022年に282億2,000万米ドルと評価され、2023年の303億1,000万米ドルから2031年には536億5,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは7.40％で成長する見通しです。

世界の避妊薬市場は、家族計画に対する意識の高まり、性感染症（STI）の増加、効果的な避妊ソリューションに対する需要の高まりに後押しされ、力強い成長を遂げています。長時間作用型可逆的避妊薬（LARC）や多様な利用可能な選択肢を含む主要な進歩が、市場の拡大をさらに刺激しています。リプロダクティブ・ヘルス（性と生殖に関する健康）を推進する政府のイニシアティブは、市場環境を強化しています。しかし、社会的烙印、文化的障壁、特定地域でのアクセス制限などの課題が、成長の妨げになることもあります。こうした障害にもかかわらず、女性の健康への関心が高まり、エンパワーメントのためのツールとして避妊が広く受け入れられていることから、世界の避妊薬市場は今後も成長を続けるものと思われます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Bayer AG
Pfizer Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Organon & Co.
Agile Therapeutics
Mayer Laboratories, Inc.
CooperSurgical, Inc.
Afaxys, Inc.
Mylan N.V.（Viatris）
DKT International
Medisafe Distribution Inc.
Veru Inc.
Cipla Ltd.
Lupin Pharmaceuticals
Mithra Pharmaceuticals
Pregna International Limited
Fuji Latex Co., Ltd.
Karex Berhad
Cupid Limited

結論と推奨事項

Product Code: SQMIG35I2273

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is experiencing robust growth, propelled by heightened awareness of family planning, a rise in sexually transmitted infections (STIs), and an increased demand for effective contraceptive solutions. Key advancements, including long-acting reversible contraceptives (LARCs) and a diverse range of available options, are further stimulating market expansion. Government initiatives promoting reproductive health enhance market conditions. However, challenges such as social stigma, cultural barriers, and limited access in certain regions can hinder growth. Despite these obstacles, the growing focus on women's health and the broadening acceptance of contraception as a tool for empowerment are poised to foster continued growth in the global contraceptives market in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segmental Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for the global contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As communities become more informed about the critical role of contraception in managing population growth and improving women's health, the demand for contraceptive options has surged considerably. This uptick is further bolstered by government initiatives and programs that advocate for family planning, as well as the dedicated efforts of various organizations working to enhance public understanding of contraceptive methods. Consequently, the convergence of education, policy support, and advocacy has fueled substantial growth within the contraceptives market.

Restraints in the Contraceptives Market

The global contraceptives market faces significant constraints primarily due to cultural and religious barriers that impede the acceptance and utilization of contraceptives in various regions. In many communities, prevailing cultural and religious norms discourage or outright prohibit contraceptive use, resulting in diminished adoption rates. Additionally, insufficient accessibility, particularly in rural and remote areas, compounds these challenges. Factors such as limited availability, high costs, and inadequate distribution networks further restrict access to contraceptives, especially in developing nations. Addressing these cultural and logistical obstacles is essential for fostering market expansion and achieving universal access to effective contraception methods.

Market Trends of the Contraceptives Market

The global contraceptives market is witnessing a significant trend towards the increasing adoption of long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are favored for their high efficacy and convenience, as they require minimal maintenance compared to traditional methods. As women seek reliable, hassle-free solutions, LARCs are becoming increasingly popular, reflecting a broader shift towards effective and sustainable contraceptive solutions. Technological advancements have further enhanced the appeal of LARCs, leading to the development of innovative, user-friendly products that cater to evolving consumer needs. This shift underscores a growing preference for modern contraceptive methods in the global market landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis
Trade Analysis
Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2024-2031)

Market Overview
Contraceptive Drugs
- Contraceptive Pills
- Patch
- Injectables
Contraceptive Devices
- Condom
- Male Condom
- Female Condom
- Subdermal Implants
- Intrauterine Devices (IUDS)
- Copper IUDS
- Hormonal IUDS
- Vaginal Ring
- Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2024-2031)

Market Overview
Healthcare Facilities
Pharmacies
Others

Global Contraceptives Market Size & CAGR (2024-2031)

North America (Product, Distribution Channel)
- USA
- Canada
Europe (Product, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organon & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agile Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayer Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Afaxys, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DKT International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe Distribution Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veru Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mithra Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pregna International Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fuji Latex Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Karex Berhad
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cupid Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

避妊薬の市場規模、シェア、成長分析、製品別、流通チャネル別、地域別 - 産業別予測、2024～2031年

Contraceptives Market Size, Share, Growth Analysis, By Product (Contraceptive Drugs, Contraceptive Pills), By Distribution Channel (Healthcare Facilities, Pharmacies), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

避妊薬市場規模：製品別

避妊薬市場規模：流通チャネル別

避妊薬市場規模：地域別